Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Dermatologic 1

Conditions

Hodgkin Disease 11Neoplasms 2Mycosis Fungoides 2Squamous Cell Carcinoma of Head and Neck 1Sezary Syndrome 1Mesothelioma, Malignant 1Melanoma 1Lymphomatoid Papulosis 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 64Cisplatin 44Cetuximab 26Carboplatin 25Paclitaxel 19Magnetic Resonance Spectroscopy 19Radiotherapy, Intensity-Modulated 17Nivolumab 17Radiotherapy 16Specimen Handling 15Docetaxel 14Platinum 131,2-diaminocyclohexaneplatinum II citrate 12Taxes 8Fluorouracil 8Biopsy 8atezolizumab 6Radiation 6(225)Ac-DOTA-c(RGDyK) 6dostarlimab 5cemiplimab 5Ipilimumab 5Immunoglobulin G 5Cyclophosphamide 5Surgical Procedures, Operative 4Standard of Care 4Immune Checkpoint Inhibitors 4Disulfides 4Bevacizumab 4Albumin-Bound Paclitaxel 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Squamous Cell Carcinoma of Head and Neck × Brentuximab Vedotin × 90 days × Clear all
NCT04609566 2026-03-16

Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors

Seagen Inc.

Phase 2 Completed
161 enrolled
DermatologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡